New partnership between North Central London Cancer Alliance and UCLPartners  

Logo images for North Central London Cancer Alliance and UCLPartners

North Central London Cancer Alliance (NCLCA) and UCLPartners will collaborate over the next year to improve early cancer diagnosis, enhance patient experience, and tackle local health inequalities. 

This joint working will boost local efforts to support the ambition of the NHS Long Term Plan to diagnose 75% of cancers at stage 1 and 2 by 2028.   

By bringing together NCLCA’s deep understanding of the local cancer care ecosystem with UCLPartners’ expertise identifying appropriate cutting-edge, innovative solutions that address clearly articulated needs, the partnership has the potential to make great strides in improving cancer care.  

Initial work will focus on improving patient outcomes for cancer types which currently have low rates of early diagnosis across North Central London, by harnessing the power of early insights and innovation horizon scans. Working with local stakeholders and industry, we will identify, test and pilot novel solutions which address the unmet needs of the population across defined cancer pathways. To that extent, UCLPartners will also develop an Innovation Triage Framework to support early innovation identification by NCLCA. 

Ali Malik, Managing Director of North Central London Cancer Alliance, commented: “We are excited by this partnership and are confident that by joining forces with UCLPartners we will have a greater impact in North Central London as we look to improve our priority areas of early diagnosis, health inequalities, and patient experience. UCLPartners offers a new opportunity for the Alliance to develop innovative concepts in cancer and robustly evaluate the impacts they make to support the future sustainability of our work. I look forward to seeing what this partnership will achieve for our patients and workforce in 2024/25 and beyond.”  

Ilias Zapantis, Director of Discovery at UCLPartners, said: “UCLPartners is a problems first health innovation partnership, and we are excited to collaborate with NCLCA to work together in identifying the most pressing challenges across different cancer pathways to explore what innovative solutions can be co-created with our local system, industry, and population to improve patient outcomes and tackle health inequalities.” 

Google Translate
Scroll to Top
Skip to content